We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.79B
AUM Growth
-$19.8M
Cap. Flow
-$506M
Cap. Flow %
-7.46%
Top 10 Hldgs %
64.12%
Holding
139
New
17
Increased
28
Reduced
77
Closed
11

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$41.2M
2
HDB icon
HDFC Bank
HDB
+$38.7M
3
UNP icon
Union Pacific
UNP
+$29.7M
4
MSFT icon
Microsoft
MSFT
+$28.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 34.47%
2 Healthcare 19.26%
3 Communication Services 16.08%
4 Consumer Discretionary 11.63%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QIWI
101
DELISTED
QIWI PLC
QIWI
$361K 0.01%
17,875
-10,700
-37% -$290K
AWK icon
102
American Water Works
AWK
$26.9B
$356K 0.01%
6,680
+1,130
+20% +$58.5K
AZO icon
103
AutoZone
AZO
$51.2B
$326K ﹤0.01%
527
+350
+198% +$197K
CMCSA icon
104
Comcast
CMCSA
$86.8B
$324K ﹤0.01%
11,180
+4,780
+75% +$131K
EIX icon
105
Edison International
EIX
$30.5B
$291K ﹤0.01%
4,450
+1,250
+39% +$77.7K
VZ icon
106
Verizon
VZ
$200B
$287K ﹤0.01%
+6,140
New +$300K
TSM icon
107
TSMC
TSM
$1.97T
$272K ﹤0.01%
+12,150
New +$265K
NBIS
108
Nebius Group N.V.
NBIS
$39.2B
$271K ﹤0.01%
15,100
-10,100
-40% -$243K
EVOK
109
DELISTED
Evoke Pharma
EVOK
$266K ﹤0.01%
313
DFS
110
DELISTED
Discover Financial Services
DFS
$256K ﹤0.01%
3,910
+2,510
+179% +$161K
PCG icon
111
PG&E
PCG
$39B
$256K ﹤0.01%
4,810
+810
+20% +$40.1K
PM icon
112
Philip Morris
PM
$314B
$231K ﹤0.01%
2,835
+1,755
+163% +$151K
HRL icon
113
Hormel Foods
HRL
$14.4B
$226K ﹤0.01%
8,660
+1,460
+20% +$38.5K
TTM
114
DELISTED
Tata Motors Limited
TTM
$209K ﹤0.01%
+4,950
New +$221K
GIS icon
115
General Mills
GIS
$20.4B
$203K ﹤0.01%
3,800
-155,460
-98% -$8.04M
TBPH icon
116
Theravance Biopharma
TBPH
$876M
$179K ﹤0.01%
11,987
-9,870
-45% -$172K
CMS icon
117
CMS Energy
CMS
$23B
$164K ﹤0.01%
4,730
-1,420
-23% -$46.4K
SYK icon
118
Stryker
SYK
$134B
$141K ﹤0.01%
1,500
-1,800
-55% -$160K
ROST icon
119
Ross Stores
ROST
$80.2B
$136K ﹤0.01%
2,880
+480
+20% +$20.3K
ENB icon
120
Enbridge
ENB
$121B
$129K ﹤0.01%
+2,500
New +$118K
ACN icon
121
Accenture
ACN
$106B
$122K ﹤0.01%
1,370
+230
+20% +$19.1K
AON icon
122
Aon
AON
$80.1B
$119K ﹤0.01%
1,260
+210
+20% +$18.8K
KDP icon
123
Keurig Dr Pepper
KDP
$42.3B
$116K ﹤0.01%
1,620
+270
+20% +$18.7K
TMO icon
124
Thermo Fisher Scientific
TMO
$215B
$112K ﹤0.01%
890
+150
+20% +$18.2K
INFY icon
125
Infosys
INFY
$50.6B
$106K ﹤0.01%
+13,440
New +$109K

Similar funds

C WorldWide Group's Q4 2014 Portfolio in Review

As of Q4 2014, C WorldWide Group held 139 positions worth $6.79B, down 0.29% from $6.81B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

C WorldWide Group withdrew a net $506M in Q4 2014, closing 11 positions and reducing 77 holdings. Its most notable exit was AUXILIUM PHARAMCEUTICALS INC, an estimated $8.32M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, C WorldWide Group opened a new position in AUSPEX PHARMACEUTICALS INC COM STK (DE) worth $5.14M.

  • C WorldWide Group's largest Q4 2014 buy was AUSPEX PHARMACEUTICALS INC COM STK (DE): 97,921 shares worth $5.14M.
  • C WorldWide Group added most to SALIX PHARMACEUTICALS LTD DEL in Q4 2014, an estimated $17M increase.
  • C WorldWide Group's biggest Q4 2014 reduction was Visa, cutting an estimated $41.2M.
  • C WorldWide Group fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $8.32M.
  • C WorldWide Group's ten largest holdings make up 64% of its $6.79B portfolio in Q4 2014.
  • C WorldWide Group opened 17 new positions and closed 11 in Q4 2014.
  • C WorldWide Group's portfolio value fell 0.29% quarter-over-quarter to $6.79B.

Based on C WorldWide Group's 13F filing for Q4 2014, filed 11 Feb 2015.